Spruce Biosciences News and Activities

Presence

Spruce Biosciences develops medicines for rare endocrine disorders. Its main services are drug research and clinical development for patients, healthcare providers, and specialty care partners.

Spruce Biosciences products and services overview:

Drug development
Clinical research
Rare disease therapies
Endocrine treatments

Revenue: ~$0 million

Employees: 35

Headquarters: South San Francisco, United States (USA)

Spruce Biosciences is owned by Harbour Biomed.

Harbour Biomed is a company listed under the stock ticker 2142 (CN).

Harbour Biomed has a direct presence in 2 countries.

Acquisition, funding and merger involving Harbour Biomed.

Harbour Biomed has just announced a $90 Million fundraising (posted on December 26 2025).

Executives

View the org chart displaying its 21 main executives

Most searched biographies at Spruce Biosciences

Popular executive movements at Spruce Biosciences

Agnieszka Jurecka has joined the company as Vice President, Medical Affairs (posted on June 22 2026).
Eric Jordan has joined the company as Vice President, Marketing (posted on June 16 2026).
Tina Gullotta has joined the company as Vice President, Finance and Corporate Controller (posted on June 16 2026).

Click here to view some more movements at Spruce Biosciences